# Bahman Guyuron – FDA Inspection, Jun 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/bahman-guyuron/7f356742-5071-4e5d-a90b-d2d3d27bd022
Source feed: FDA_Inspections

> FDA inspection 1015061 of Bahman Guyuron, June 21, 2017. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015061
- Company Name: Bahman Guyuron
- Inspection Date: 2017-06-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-t-rybus/246aad79-6370-42e2-af6e-c0079c1bcbc6)

Company: https://www.keypedia.com/companies/bahman-guyuron/b7df6c60-32f5-4ccb-b2cf-dcb56551f4ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c